Medical AI company ARPI (CEO Kim Joong-hee) announced that it participated in the “Mayo Clinic Platform_Accelerate Showcase,” held in Rochester, Minnesota, United States, from the 7th to the 8th. ARPI was the only Korean company among the 25 global healthcare companies participating in the event and presented its AI electrocardiogram (ECG) analysis solution, “ECG Buddy.”

Mayo Clinic is regarded as the most prestigious medical institution in the United States, and Mayo Clinic Platform_Accelerate is a global program that discovers and nurtures next-generation digital healthcare innovation companies. The showcase was attended in large numbers by key figures in the medical sector, including heads of major clinical departments at Mayo Clinic, its management, investors, and stakeholders in the Minnesota healthcare ecosystem.

During the two-day event, ARPI operated a booth to introduce ECG Buddy, and CEO Kim Joong-hee and the ARPI delegation were present in person to engage in in-depth networking with global medical innovation stakeholders.

Kim Joong-hee, CEO of ARPI, said, “It is highly meaningful to be able to participate in this program organized by Mayo Clinic, one of the world’s leading institutions in medical innovation, as a Korean company,” and added, “Through this participation, we were able to reconfirm that ECG Buddy has sufficient competitiveness and potential on the global stage. We will continue to take on challenges in the global market going forward.”

Meanwhile, ECG Buddy is an AI-based ECG analysis solution optimized for emergency room environments. It has obtained approval from the Ministry of Food and Drug Safety (MFDS) and CE MDR certification, and is currently deployed in more than 90 hospitals in Korea, supporting over 200,000 ECG analyses per month.

Popular News